Literature DB >> 6311233

An assessment of physiological finger tremor as an indicator of beta-adrenoceptor function.

J M Arnold, D G McDevitt.   

Abstract

Physiological finger tremor has been assessed as an indicator of beta-adrenoceptor function. Tremor was not correlated with the sex, age, weight or height of the subjects and was stable over 5 min when the hand and fingers were held horizontally. It was not increased by mental arithmetic, the Valsalva manoeuvre or 3 min exercise. Satisfactory dose-response curves could be constructed for the isoprenaline enhanced increases in finger tremor. In six subjects, practolol 120 mg produced a small shift to the right of the isoprenaline dose-response curve for finger tremor (dose ratio 2.1) but propranolol 40 mg was seven times more effective (dose ratio 17.1). Physiological finger tremor appears to be a stable parameter which may be useful in the investigation of the selectivity of beta-adrenoceptor blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311233      PMCID: PMC1427990          DOI: 10.1111/j.1365-2125.1983.tb04981.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Evaluation of skeletal muscle tremor due to bronchodilator agents.

Authors:  G Thiringer; N Svedmyr
Journal:  Scand J Respir Dis       Date:  1975-08

2.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.

Authors:  I Brick; K J Hutchison; D G McDevitt; I C Roddie; R G Shanks
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

3.  The relationship between plasma catecholamine concentration and pulse rate during exercise and standing.

Authors:  N J Christensen; O Brandsborg
Journal:  Eur J Clin Invest       Date:  1973-07       Impact factor: 4.686

4.  A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol.

Authors:  C R Cleaveland; R E Rangno; D G Shand
Journal:  Arch Intern Med       Date:  1972-07

5.  Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.

Authors:  J J Lertora; A L Mark; J Johannsen; W R Wilson; F M Abboud
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Peripheral beta-adrenergic receptors concerned with tremor.

Authors:  C D Marsden; T H Foley; D A Owen; R G McAllister
Journal:  Clin Sci       Date:  1967-08       Impact factor: 6.124

7.  Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.

Authors:  D G McDevitt; H C Brown; S G Carruthers; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

8.  Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.

Authors:  S Larsson; N Svedmyr
Journal:  Scand J Respir Dis       Date:  1977

9.  Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.

Authors:  J F De Plaen; A Amery; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

10.  Assessment of selective beta-adrenoceptor blockade in man.

Authors:  R H Briant; C T Dollery; T Fenyvesi; C F George
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

View more
  9 in total

1.  Enhancement of physiological finger tremor by intravenous isoprenaline infusions in man: evaluation of its role in the assessment of beta-adrenoceptor antagonists.

Authors:  J M Arnold; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

2.  Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.

Authors:  P C O'Connor; J M Arnold; A N Brown; R J Francis; M B Finch; D B Galloway; D W Harron; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

3.  Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

4.  Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.

Authors:  K F Whyte; P J De Vane; R Whitesmith; A Kelman; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

5.  The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.

Authors:  T C Tham; J P McKaigue; S Guy; R G Shanks; J G Riddell
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

6.  Studies of the agonist and antagonist activity of cicloprolol in man.

Authors:  P M McCaffrey; M Burke; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.

Authors:  T H Pringle; J G Riddell; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.

Authors:  P M McCaffrey; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

9.  Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

Authors:  T H Pringle; P C O'Connor; A J McNeill; M B Finch; J G Riddell; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.